Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06535802 · ClinicalTrials.gov registry record
iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men
A clinical trial of Prostate Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 53
- Enrollment target
- 1
- Study location
NCT06535802 is a study of Prostate Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 53 participants, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06535802, a study of Prostate Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to determine the acceptance and effectiveness of a virtual robot assistant model at a urology clinic.
Conditions Studied
Interventions
- OTHER Survey
- OTHER Focus group
- OTHER Clinician Interviews
- OTHER Intervention testing
- OTHER Follow-up Interview
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2023-11-20 |
| Est. Completion | 2026-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06535802
The ClinicalTrials.gov registry entry for NCT06535802 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Survey is the first listed.
NCT06535802 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06535802 about?
NCT06535802 is a clinical study titled "iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men". This study is being done to determine the acceptance and effectiveness of a virtual robot assistant model at a urology clinic.
What is the current status of trial NCT06535802?
This trial is currently recruiting. The enrollment target is 53 participants. The study started on 2023-11-20. Estimated completion is 2026-12-01.
What conditions does trial NCT06535802 study?
This clinical trial studies the following conditions: Prostate Carcinoma.
What interventions are being tested in trial NCT06535802?
The interventions under investigation include: Survey (OTHER), Focus group (OTHER), Clinician Interviews (OTHER), Intervention testing (OTHER), Follow-up Interview (OTHER).
Who is sponsoring clinical trial NCT06535802?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06535802 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
RECRUITING · NA
-
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
RECRUITING · Early Phase 1
-
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
RECRUITING
-
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
RECRUITING · Phase 2
-
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
RECRUITING · Early Phase 1
-
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.